Providers Seek Oncology IT Solutions that Successfully Combine Integration and Functionality

    OREM, UT, September 07, 2011 /24-7PressRelease/ -- Oncology is an extremely complex discipline. Part of that complexity results from physicians moving between hospitals and clinics, patients moving between infusion suites and radiation oncology facilities, and medical records not being always immediately at hand. The new KLAS report "Oncology IS 2011: Integrating the Island" shares study results of oncology best-of-breed vendors and indicates that providers have invited enterprise HIT vendors to enter the oncology IT arena.

While most practices appear to be relieved that meaningful use (MU) incentives have raised the bar for oncology IS vendors and brought both enterprise EMR and niche market HIT vendors into the market, most are not fully satisfied with the current offerings. Best-of-breed vendors have picked up their game, but are being forced to allocate precious resources to accommodate MU requirements; enterprise vendors are coming in with guns blazing, but appear to be focusing on medical oncology only.

"Full integration is critical in the new world of accountable care," said Monique Rasband, author of the report. "At this point in time no one is quite hitting all the targets; enterprise vendors are offering products without radiation oncology applications, and best-of-breed vendors are pushing to interface suites to enterprise and other systems."

Varian ARIA's score improved by eight points over the past year, moving this niche solution from last place in the 2010 report (71.1 out of 100) to first place in this year's report (79.6) and closer to the performance scores of the other oncology solutions. Elekta/MOSAIQ (78.7) and IntrinsiQ/IntelliDose (74.7) both continued to perform well this year, ranking second and third respectively. The competition for these three best-of breed vendors is tightening, as evidenced by their performance scores. Overall, Varian customers feel that the solution delivers a solid offering across the oncology suite, Elekta's large client-base reports that MOSAIQ is a good oncology partner with a system that shows continued improvement and works well in the ambulatory space, and IntrinsiQ users say the solution offers robust oncology tools that complement any EMR.

Interestingly, it was enterprise solution Epic Beacon that received the highest overall performance score (83.4) this year, in spite of not being ranked in the report because KLAS was unable to validate enough users of the solution in cancer centers and ambulatory clinics. While a large portion of the data came from IT, Epic customers feel secure in the company's high level of commitment, despite some limited functionality, and they believe that the solution's progress is promising. Early findings were included for BMSi ONCOCHART and US Oncology iKnowMed (recently acquired by heavy-hitter McKesson); due to limited sample sizes these products were not ranked in the report. KLAS was able to validate a number of sites that have contracted Cerner PowerChart Oncology and are planning to go live in the acute space. Cerner also was not ranked in this report due to limited sample.

"Newcomers BMSi and US Oncology are gaining momentum in the oncology IT space," added Rasband. "Their nimbleness combined with web-based platforms make their products less expensive, easier to use, and allows vendors to execute quick upgrades. Once iKnowMed gets the needed integration components, they could be a formidable competitor in this market segment."

To learn more about the oncology IT market, including the strengths and weaknesses of measured vendors, the report "Oncology IS 2011: Integrating the Island" is available to healthcare providers online for a significant discount off the standard retail price. With vendors showing steady improvement since last year, it will be interesting to watch as provider satisfaction continues to unfold. To purchase, healthcare providers and vendors can visit www.KLASresearch.com/reports.

KLAS is a research firm specializing in monitoring and reporting on the performance of healthcare vendors. KLAS' mission is to improve delivery by independently measuring vendor performance for the benefit of our healthcare provider partners, consultants, investors, and vendors. Working together with executives from more than 4500 hospitals and more than 2500 clinics, KLAS delivers timely reports, trends, and statistics that provide a solid overview of vendor performance in the industry. KLAS measures performance of software, professional services, medical equipment, and infrastructure vendors. For more information, go to www.KLASresearch.com, email [email protected], or call 1-800-920-4109 to speak with a KLAS representative. Follow KLAS on Twitter at www.twitter.com/KLASresearch.

# # #